Identification of novel BCR::ABL1 kinase domain mutation in patients with chronic myeloid leukaemia and imatinib resistance.

Autor: Yusoff YM; National Institutes of Health, Institute for Medical Research, Cancer Research Centre, Haematology Unit, 40170 Shah Alam, Selangor, Malaysia. yuslinamy@moh.gov.my., Seman ZA; National Institutes of Health, Institute for Medical Research, Cancer Research Centre, Haematology Unit, 40170 Shah Alam, Selangor, Malaysia., Anoar SZ; National Institutes of Health, Institute for Medical Research, Cancer Research Centre, Haematology Unit, 40170 Shah Alam, Selangor, Malaysia., Said SSM; Hospital Tunku Azizah, Department of Pathology, Ministry of Health Malaysia, 50300 Kuala Lumpur, WP Kuala Lumpur, Malaysia., Azman N; Hospital Tunku Azizah, Department of Pathology, Ministry of Health Malaysia, 50300 Kuala Lumpur, WP Kuala Lumpur, Malaysia., Kamaluddin NR; National Institutes of Health, Institute for Medical Research, Cancer Research Centre, Haematology Unit, 40170 Shah Alam, Selangor, Malaysia., Abdullah J; National Institutes of Health, Institute for Medical Research, Cancer Research Centre, Haematology Unit, 40170 Shah Alam, Selangor, Malaysia., Yacob SSM; National Institutes of Health, Institute for Medical Research, Cancer Research Centre, Haematology Unit, 40170 Shah Alam, Selangor, Malaysia., Esa E; National Institutes of Health, Institute for Medical Research, Cancer Research Centre, Haematology Unit, 40170 Shah Alam, Selangor, Malaysia.

Publikováno v: The Malaysian journal of pathology [Malays J Pathol] 2024 Dec; Vol. 46 (3), pp. 431-439.